Third Pole
Third Pole Therapeutics is dedicated to reimagining heart and lung therapy by making life-saving benefits of inhaled nitric oxide accessible on demand worldwide. The company develops innovative cardio-pulmonary therapies, including portable inhaled nitric oxide delivery systems, to treat conditions like pulmonary hypertension and assist in COVID-19 treatment.
Industries
Nr. of Employees
small (1-50)
Third Pole
Patents
Systems and methods for preventing and treating infections with nitric oxide
US-11827989-B2
View Details
Systems and methods for preventing and treating infections with nitric oxide
US-11827989-B2
View DetailsProducts
Wearable/tankless inhaled nitric oxide delivery system (portable platform)
A portable, wearable system that generates and delivers inhaled nitric oxide on demand without compressed gas cylinders; intended for neonatal and adult pulmonary hypertension and other respiratory indications.
eNOfit
eNOfit is a proprietary, tankless, on-demand, electrically generated inhaled Nitric Oxide (iNO) technology that is a safe, accurate and reliable lightweight, wearable device that makes iNO from electricity and the air we breathe, creating a make it and take therapy free from the hazards of compressed gas storage.
Third Pole Therapeutics Portable and Miniaturized Inhaled Nitric Oxide Platform
A portable and miniaturized platform technology to generate inhaled Nitric Oxide (iNO) on demand, accurately, safely, and reliably for hospital and mobile use to treat severe cardiopulmonary diseases and lung infections.
eNOcare
An investigational product designed to generate nitric oxide from air and electricity on-demand and on-site, enabling tankless nitric oxide therapy for various respiratory and infectious diseases.
Wearable/tankless inhaled nitric oxide delivery system (portable platform)
A portable, wearable system that generates and delivers inhaled nitric oxide on demand without compressed gas cylinders; intended for neonatal and adult pulmonary hypertension and other respiratory indications.
eNOfit
eNOfit is a proprietary, tankless, on-demand, electrically generated inhaled Nitric Oxide (iNO) technology that is a safe, accurate and reliable lightweight, wearable device that makes iNO from electricity and the air we breathe, creating a make it and take therapy free from the hazards of compressed gas storage.
Third Pole Therapeutics Portable and Miniaturized Inhaled Nitric Oxide Platform
A portable and miniaturized platform technology to generate inhaled Nitric Oxide (iNO) on demand, accurately, safely, and reliably for hospital and mobile use to treat severe cardiopulmonary diseases and lung infections.
eNOcare
An investigational product designed to generate nitric oxide from air and electricity on-demand and on-site, enabling tankless nitric oxide therapy for various respiratory and infectious diseases.
Services
Establishing collaborations with pharmaceutical partners for co-development and potential commercialization of inhaled gas therapies.
Support for planning and executing early-stage clinical trials, including feasibility studies and initial patient dosing for device-based inhaled therapies.
Establishing collaborations with pharmaceutical partners for co-development and potential commercialization of inhaled gas therapies.
Support for planning and executing early-stage clinical trials, including feasibility studies and initial patient dosing for device-based inhaled therapies.
Expertise Areas
- Inhaled nitric oxide therapy delivery
- Wearable and portable medical device development
- Gas generation technologies for therapeutic gases
- Clinical trial management for early feasibility device studies
Key Technologies
- Pulsed electrical discharge nitric oxide generation
- Wearable inhaled gas delivery platforms
- Tankless/portable inhaled gas systems
- Gas impurity detection and removal techniques